The future of febuxostat after the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial: who CARES?

被引：11

作者：

Katsiki, Niki ^{[1
]}

Borghi, Claudio ^{[2
]}

机构：

[1] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Propedeut Dept Internal Med 2, Thessaloniki, Greece

[2] Univ Bologna, Policlin S Orsola Malpighi, Dept Med & Surg Sci, Bologna, Italy

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2018年 / 19卷 / 17期

关键词：

Febuxostat; allopurinol; uric acid; cardiovascular; sodium-glucose co-transporter 2 inhibitors; ALL-CAUSE MORTALITY; SERUM URIC-ACID; CARDIAC-SURGERY PATIENTS; HYPERURICEMIA; DISEASE; RISK; MANAGEMENT; OUTCOMES;

D O I：

10.1080/14656566.2018.1532503

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：1853 / 1856

页数：4

共 34 条

[1]

The management of hyperuricemia: back to the pathophysiology of uric acid [J].

Borghi, Claudio .

CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 :1-4

[2]

Serum Uric Acid and Cardiometabolic Disease Another Brick in the Wall? [J].

Borghi, Claudio ;

Francesco, Arrigo ;

Cicero, Giuseppe .

HYPERTENSION, 2017, 69 (06) :1011-1013

[3]

Serum uric acid and the risk of cardiovascular and renal disease [J].

Borghi, Claudio ;

Rosei, Enrico Agabiti ;

Bardin, Thomas ;

Dawson, Jesse ;

Dominiczak, Anna ;

Kielstein, Jan T. ;

Manolis, Athanasios J. ;

Perez-Ruiz, Fernando ;

Mancia, Giuseppe .

JOURNAL OF HYPERTENSION, 2015, 33 (09) :1729-1741

[4]

Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis [J].

Braga, Federica ;

Pasqualetti, Sara ;

Ferraro, Simona ;

Panteghini, Mauro .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (01) :7-15

[5]

Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study [J].

Chen, Jiunn-Horng ;

Lan, Joung-Liang ;

Cheng, Chi-Fung ;

Liang, Wen-Miin ;

Lin, Hsiao-Yi ;

Tsay, Gregory J. ;

Yeh, Wen-Ting ;

Pan, Wen-Harn .

JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) :1694-1701

[6]

Polypill, hypertension and medication adherence: The solution strategy [J].

Cimmaruta, D. ;

Lombardi, N. ;

Borghi, C. ;

Rosano, G. ;

Rossi, F. ;

Mugelli, A. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 252 :181-186

[7]

Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials [J].

Derosa, Giuseppe ;

Maffioli, Pamela ;

Sahebkar, Amirhossein .

PHARMACOLOGICAL RESEARCH, 2015, 102 :63-70

[8]

Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A US Payer Perspective [J].

Gandhi, Pranav K. ;

Gentry, William M. ;

Ma, Qinli ;

Bottorff, Michael B. .

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (02) :165-175

[9]

The British Society for Rheumatology Guideline for the Management of Gout [J].

Hui, Michelle ;

Carr, Alison ;

Cameron, Stewart ;

Davenport, Graham ;

Doherty, Michael ;

Forrester, Harry ;

Jenkins, Wendy ;

Jordan, Kelsey M. ;

Mallen, Christian D. ;

McDonald, Thomas M. ;

Nuki, George ;

Pywell, Anthony ;

Zhang, Weiya ;

Roddy, Edward .

RHEUMATOLOGY, 2017, 56 (07) :1056-1059

[10]

Katsiki N, 2018, J CLIN HYPERTENS

← 1 2 3 4 →